MEDICAL TEST KITS SELF MONITORING

Brand Owner (click to sort) Address Description
ENABLING TECHNOLOGIES FOR DIAGNOSTICS Pelikan Technologies, Inc. 1072 East Meadow Circle Palo Alto CA 94303 Medical test kits for self-monitoring of diabetes, comprised primarily of diagnostic reagents, test strips and lancets; blood glucose test strips for diagnosis, testing, and monitoring of diabetes; diagnostic reagents for clinical or medical laboratory or home use for the diagnosis, testing and monitoring of diabetes;Medical devices for testing and monitoring of diabetes, namely, blood glucose monitors, blood glucose testing meters, and blood glucose testing devices in the nature of lancets, automatic lancets, mechanical lancets, electronic lancets, electro-mechanical lancets and electronically controlled lancets separately or integrated into blood glucose monitors or meters;
ENABLING TECHNOLOGIES FOR DIAGNOSTICS Pelikan Technologies, Inc. 1072 East Meadow Circle Palo Alto CA 94303 medical test kits for self-monitoring of diabetes;Medical devices for diagnostic testing and self-monitoring purposes, namely, blood glucose testing devices;
HEALTHY SAMPLING Pelikan Technologies, Inc. 1072 East Meadow Circle Palo Alto CA 94303 Medical test kits for self-monitoring of diabetes, comprised primarily of test strips and lancets; blood glucose test strips for diagnosis, testing and monitoring of diabetes;Medical devices for testing and monitoring of diabetes, namely, blood glucose testing meters, and blood glucose testing devices in the nature of lancets, automatic lancets, mechanical lancets, electronic lancets, electro-mechanical lancets and electronically controlled lancets separately or integrated into blood glucose meters;
PELIKAN SUN Pelikan Technologies, Inc. 1072 East Meadow Circle Palo Alto CA 94303 Medical test kits for self-monitoring of diabetes, comprised primarily of diagnostic reagents, test strips and lancets; blood glucose test strips for diagnosis, testing, and monitoring of diabetes; diagnostic reagents for clinical or medical laboratory or home use for the diagnosis, testing and monitoring of diabetes;Medical devices for testing and monitoring of diabetes, namely, blood glucose monitors, blood glucose testing meters, and blood glucose testing devices in the nature of lancets, automatic lancets, mechanical lancets, electronic lancets, electro-mechanical lancets and electronically controlled lancets separately or integrated into blood glucose monitors or meters;
PELIKAN TECHNOLOGIES Pelikan Technologies, Inc. 1072 East Meadow Circle Palo Alto CA 94303 Medical test kits for self-monitoring of diabetes, comprised primarily of diagnostic reagents, test strips and lancets; blood glucose test strips for diagnosis, testing, and monitoring of diabetes; diagnostic reagents for clinical or medical laboratory or home use for the diagnosis, testing and monitoring of diabetes;Medical devices for testing and monitoring of diabetes, namely, blood glucose monitors, blood glucose testing meters, and blood glucose testing devices in the nature of lancets, automatic lancets, mechanical lancets, electronic lancets, electro-mechanical lancets and electronically controlled lancets separately or integrated into blood glucose monitors or meters;TECHNOLOGIES;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention provides methods, compositions and kits for discriminating between COX-1 and COX-2 activity. In particular, the prevent invention provides for the detection and/or measurement of COX-2 activity in subjects, samples thereof, and in laboratory tests. The present invention discloses that 2-arachidonylglycerol is a COX-2 selective substrate which is metabolized by COX-2 to prostaglandin glycerol esters (PG-Gs) and that the diversity of PG-Gs parallels that of arachidonic acid derived metabolites of COX. The present invention also provides certain novel COX-2 selective metabolites including prostaglandin I2-glycerol ester (PGI2-G) and 6-keto-prostaglandin F1a-glycerol ester. Methods and kits are described for detecting COX-2 activity comprising detecting PG-Gs (including the novel PG-Gs disclosed herein). Uses for these methods and kits include the detection and monitoring of inflammation and tumors or cancer. Additional uses include the monitoring of test agents in assays to screen for COX-2 specific inhibitors and other laboratory uses.